Tubulointerstitial nephritis in a patient with probable autoimmune lymphoproliferative syndrome

Journal of Pediatric Hematology/Oncology

Volumn 35, Issue 5, 2013, Pages

  Glerup, Mia ^a   Herlin, Troels ^a   Rittig, Søren ^a   Grønbæk, Kirsten ^c   Hokland, Marianne ^b   Hasle, Henrik ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

^b AARHUS UNIVERSITY   (Denmark)

^c Rigshospitalet   (Denmark)

Author keywords

Apoptosis; Autoimmune lymphoproliferative syndrome; DNT cells; Glomerulonephritis; TIN

Indexed keywords

CREATININE; IMMUNOGLOBULIN A; PREDNISONE;

ARTICLE; AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME; CASE REPORT; CHILD; CREATININE CLEARANCE; DISEASE ASSOCIATION; DISEASE SEVERITY; ECHOGRAPHY; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; FEVER; HEMATURIA; HUMAN; HUMAN TISSUE; HYPERGAMMAGLOBULINEMIA; HYPERTENSION; IMMUNOGLOBULIN BLOOD LEVEL; INTERSTITIAL NEPHRITIS; KIDNEY BIOPSY; KIDNEY FAILURE; PRESCHOOL CHILD; PRIORITY JOURNAL; SMALL VESSEL VASCULITIS; SPLENOMEGALY; UREMIA; VOMITING;

ANTI-INFLAMMATORY AGENTS; AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME; CHILD, PRESCHOOL; FEMALE; HUMANS; NEPHRITIS, INTERSTITIAL; PREDNISONE;

EID: 84880315265     PISSN: 10774114     EISSN: 15363678     Source Type: Journal    
DOI: 10.1097/MPH.0b013e31828ac9fe     Document Type: Article

References (13)

1. Teachey DT, Seif AE, Grupp SA. Advances in the management and understanding of autoimmune lymphoproliferative syndrome (ALPS). Br J Haematol. 2010;148:205-216.
2. Dowdell KC, Niemela JE, Price S, et al. Somatic FAS mutations are common in patients with genetically undefined autoimmune lymphoproliferative syndrome. Blood. 2010; 115:5164-5169.
3. Magerus-Chatinet A, Stolzenberg MC, Loffredo MS, et al. FAS-L, IL-10, and double-negative CD4-CD8-TCR alpha/beta+ T cells are reliable markers of autoimmune lymphoproliferative syndrome (ALPS) associated with FAS loss of function. Blood. 2009;113:3027-3030.
4. Oliveira JB, Bleesing JJ, Dianzani U, et al. Revised diagnostic criteria and classification for the autoimmune lymphoproliferative syndrome (ALPS): report from the 2009 NIH International Workshop. Blood. 2010;116:e35-e40.
5. Lenardo MJ, Oliveira JB, Zheng L, et al. ALPS-ten lessons from an international workshop on a genetic disease of apoptosis. Immunity. 2010;32:291-295.
6. Bleesing JJH, Johnson J, Zhang K. Autoimmune lymphoproliferative syndrome. In: Pagon RA, Bird TD, Dolan CR, et al, eds. GeneReviews [Internet]. Seattle, WA: University of Washington, Seattle; 1993;2006.
7. Holzelova E, Vonarbourg C, Stolzenberg MC, et al. Autoimmune lymphoproliferative syndrome with somatic Fas mutations. N Engl J Med. 2004;351:1409-1418.
8. Teachey DT. Somatic ALPS: a FAScinating condition. Blood. 2010;115:5125-5126.
9. Glerup M, Thelle T, Gronbaek K, et al. Splenectomy in two children with autoimmune lymphoproliferative syndrome and massive splenomegaly. Pediatr Blood Cancer. 2009;53: 1124-1126.
10. Kanegane H, Vilela MM, Wang Y, et al. Autoimmune lymphoproliferative syndrome presenting with glomerulonephritis. Pediatr Nephrol. 2003;18:454-456.
11. Vaishnaw AK, Toubi E, Ohsako S, et al. The spectrum of apoptotic defects and clinical manifestations, including systemic lupus erythematosus, in humans with CD95 (Fas/APO-1) mutations. Arthritis Rheum. 1999;42:1833-1842.
12. Sneller MC, Straus SE, Jaffe ES, et al. A novel lymphoproliferative/ autoimmune syndrome resembling murine lpr/gld disease. J Clin Invest. 1992;90:334-341.
13. Neven B, Magerus-Chatinet A, Florkin B, et al. A survey of 90 patients with autoimmune lymphoproliferative syndrome related to TNFRSF6 mutation. Blood. 2011;118:4798-4807.